Table 2 Change from baseline to week 12 in KHQ domain scores by treatment group
KHQ Domain | Placebo Mean (SD) [n] | TER Mean (SD) [n] | P Value |
|---|---|---|---|
General Health Perceptions | -0.06 (17.4) [406] | -0.4 (17.6) [419] | 0.9850 |
Incontinence Impact | -8.9 (26.7) [405] | -16.0 (29.4) [417] | <0.0001 |
Role Limitations | -10.4 (29.3) [404] | -18.1 (30.7) [416] | <0.0001 |
Physical Limitations | -9.0 (28.1) [404] | -15.8 (30.1) [417] | 0.0003 |
Social Limitations | -6.3 (22.8) [402] | -8.7 (23.4) [411] | 0.0431 |
Personal Relationships | -3.5 (23.2) [265] | -5.8 (27.0) [259] | 0.4759 |
Emotions | -6.4 (24.1) [403] | -9.4 (25.0) [413] | 0.0746 |
Sleep/Energy | -4.8 (21.0) [404] | -9.9 (24.6) [415] | 0.0033 |
Severity/Coping | -6.1 (20.0) [402] | -11.9 (22.1) [414] | <0.0001 |
Symptom Severity | -1.5 (3.9) [406] | -2.9 (4.1) [419] | <0.0001 |